Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Telmijub Beta 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Jubilant Life Sciences

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telmijub Beta 50 Tablet ER

Telmijub Beta 50 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication daily with food, as directed by your physician. Continued use, even when feeling well, is crucial as hypertension is often asymptomatic; premature discontinuation can worsen your condition. Lifestyle modifications—including regular exercise, weight management, and a healthy diet—complement this treatment. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (sometimes with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and stand slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Disclose all current medications, particularly those for hypertension or heart conditions.

Uses of Telmijub Beta 50 Tablet ER

Managing elevated blood pressure

Major Benefits of Telmijub Beta 50 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmijub Beta 50 Extended-Release Tablets should be administered with a meal.

Common Side effects of Telmijub Beta 50 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telmijub Beta 50 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Telmijub Beta 50 Tablet ER with food.

How Telmijub Beta 50 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telmijub Beta 50 ER tablets, provide effective blood pressure reduction.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telmijub Beta 50 Tablet ER and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmisartan 50 mg tablets (Telmijub Beta 50) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmisartan 50mg tablets (Telmijub Beta 50) are likely safe for use while breastfeeding. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmisartan 50 mg tablets can cause drowsiness, blurred vision, dizziness, and reduced alertness. Driving is inadvisable if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Telmisartan/Amlodipine 50 mg tablets pose no safety concerns for patients with kidney disease and require no dosage modification.

LiverLiverCAUTION

Individuals with hepatic impairment should use Telmijub Beta 50 Extended-Release tablets cautiously. Dosage modification of Telmijub Beta 50 Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Telmijub Beta 50 Tablet ER :

Should you forget a dose of Telmijub Beta 50 Tablet ER, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmijub Beta 50 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Heart

FAQs on Telmijub Beta 50 Tablet ER

Telmijub Beta 50 Tablet ER Succinate may cause dizziness, particularly upon standing after lying or sitting. To minimize dizziness or fainting, rise slowly from a lying or sitting position.
Improve your health alongside Telmijub Beta 50 Tablet ER Succinate by adopting a healthier lifestyle. Quit smoking to lower your risk of heart attack and stroke. Manage your weight through diet and exercise. A balanced diet rich in fruits and vegetables, combined with regular physical activity, strengthens your heart and reduces heart attack risk.
Continue taking Telmijub Beta 50 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause serious health problems, including heart attack and stroke.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Telmijub Beta 50 Tablet E...
166
MRP 202
17% off